Results 221 to 230 of about 484,088 (306)
This study aimed to determine how microbiota compositions (via 16S rRNA sequencing) correlate with clinical outcome and metabolome (via liquid chromatography/mass spectrometry) of CBA. Sputum microbiome and metabolome profiles of CBA were well separated from COPD but not bronchiectasis, partly driven by the higher abundance of Proteobacteria in CBA ...
Zhen‐feng He+16 more
wiley +1 more source
Ribosomes: from conserved origin to functional/medical mobility and heterogeneity. [PDF]
Rivalta A+12 more
europepmc +1 more source
The Central FacilitaTOR: Coordinating Transcription and Translation in Eukaryotes. [PDF]
Adams-Brown SE, Reid KZ.
europepmc +1 more source
Built differently or defective: can RNA exosomopathies cause ribosome heterogeneity? [PDF]
Bressman ZJ, Corbett AH, Ghalei H.
europepmc +1 more source
Structural insight into the novel Thermus thermophilus SPOUT methyltransferase RlmR catalysing Um2552 formation in the 23S rRNA A-loop: a case of convergent evolution. [PDF]
Tanouti Y+10 more
europepmc +1 more source
Optimal Reference Genes for Gene Expression Analysis of Overmating Stress-Induced Aging and Natural Aging in Male <i>Macrobrachium rosenbergii</i>. [PDF]
Fan Y+9 more
europepmc +1 more source
What's New? Patients with stage II colon cancer exhibit considerable variation in prognosis. Consequently, decisions regarding the necessity of adjuvant chemotherapy in this population often rely on imperfect high‐risk criteria. Here, the authors developed a novel RNA‐based risk score, using NanoString nCounter technology, to stratify recurrence risk ...
Ulrik Korsgaard+8 more
wiley +1 more source
Nucleolar origins: challenging perspectives on evolution and function. [PDF]
Muñoz-Velasco I+2 more
europepmc +1 more source
This narrative review uniquely addresses how gut microbiota‐derived metabolites mediate overlapping pathologies of insulin resistance, neuroinflammation, and amyloidogenesis in type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), proposing a framework for dual therapeutic targeting.
Guangyi Xu+8 more
wiley +1 more source